[Clinical trials with a new beta-sympatholytic agent].
D000284:Administration, Oral; D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage* / Q000009:adverse effects; D000328:Adult; D000368:Aged; D000787:Angina Pectoris / Q000188:drug therapy*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007211:Indoles / Q000008:administration & dosage / Q000009:adverse effects; D007275:Injections, Intravenous; D008134:Long-Term Care; D008297:Male; D013607:Tablets
D000319:Adrenergic beta-Antagonists; D007211:Indoles; D013607:Tablets
Klinische Erfahrungen mit einem neuen beta-Sympathikolytikum.